Infirst Healthcare gains Granulox rights

3 January 2014 - Deborah Wilkes


Infirst Healthcare has acquired exclusive marketing rights in the UK, the US and other English-speaking countries to Sastomed's Granulox haemoglobin spray for treating chronic wounds.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: